Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$199M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$162M |
| 3 |
Rio Tinto
RIO
|
+$110M |
| 4 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$87.2M |
| 5 |
UN
Unilever NV New York Registry Shares
UN
|
+$62.8M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$309M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$92.6M |
| 3 |
Amazon
AMZN
|
+$67M |
| 4 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$66.9M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$50M |
Sector Composition
| 1 | Consumer Discretionary | 7.63% |
| 2 | Communication Services | 7.17% |
| 3 | Technology | 6.31% |
| 4 | Financials | 5.68% |
| 5 | Healthcare | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Walker & Dunlop
WD
$2.93B
| $284K | ﹤0.01% |
+5,809
| New | +$284K |
|
|
ISEE
2327
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $284K | ﹤0.01% |
+110,963
| New | +$284K |
|
2328
Advanced Energy
AEIS
$5.94B
| $283K | ﹤0.01% |
4,376
-7,410
| -63% | -$479K |
|
2329
EPAM Systems
EPAM
$8.69B
| $283K | ﹤0.01% |
3,371
+640
| +23% | +$53.7K |
|
2330
Flex
FLEX
$21.4B
| $283K | ﹤0.01% |
22,997
-41,183
| -64% | -$507K |
|
|
WMGI
2331
DELISTED
Wright Medical Group Inc
WMGI
| $283K | ﹤0.01% |
10,300
-10,901
| -51% | -$300K |
|
|
KCG
2332
DELISTED
KCG Holdings, Inc.
KCG
| $282K | ﹤0.01% |
+14,120
| New | +$282K |
|
2333
FibroGen
FGEN
$48.6M
| $281K | ﹤0.01% |
+348
| New | +$281K |
|
|
SVC
2334
Service Properties Trust
SVC
$476M
| $281K | ﹤0.01% |
9,648
+3,008
| +45% | +$87.6K |
|
2335
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$20.1M
| $281K | ﹤0.01% |
4,619
-16,775
| -78% | -$1.02M |
|
2336
VanEck Biotech ETF
BBH
$349M
| $281K | ﹤0.01% |
2,236
-6,880
| -75% | -$865K |
|
2337
Coeur Mining
CDE
$9.98B
| $281K | ﹤0.01% |
32,728
-3,425
| -9% | -$29.4K |
|
2338
Fidelity High Dividend ETF
FDVV
$6.84B
| $281K | ﹤0.01% |
10,495
-32,850
| -76% | -$880K |
|
2339
Denny's
DENN
$264M
| $280K | ﹤0.01% |
+23,793
| New | +$280K |
|
2340
Waste Connections
WCN
$45.3B
| $280K | ﹤0.01% |
4,349
-7,734
| -64% | -$498K |
|
2341
Ambarella
AMBA
$3.43B
| $279K | ﹤0.01% |
5,738
-6,657
| -54% | -$324K |
|
2342
IMAX
IMAX
$1.74B
| $279K | ﹤0.01% |
12,698
+5,735
| +82% | +$126K |
|
2343
Invesco FTSE RAFI US 1000 ETF
PRF
$8.18B
| $279K | ﹤0.01% |
13,505
-216,775
| -94% | -$4.48M |
|
|
FXJP
2344
DELISTED
PowerShares Japan Currency Hedged Low Volatility Portfolio
FXJP
| $279K | ﹤0.01% |
9,976
-7,751
| -44% | -$217K |
|
2345
BJ's Restaurants
BJRI
$684M
| $278K | ﹤0.01% |
+7,453
| New | +$278K |
|
2346
DNOW Inc
DNOW
$1.6B
| $278K | ﹤0.01% |
+17,308
| New | +$278K |
|
2347
iShares MSCI Brazil ETF
EWZ
$5.55B
| $278K | ﹤0.01% |
8,150
-289,003
| -97% | -$9.86M |
|
2348
Fidelity Value Factor ETF
FVAL
$1.04B
| $278K | ﹤0.01% |
9,520
-52,960
| -85% | -$1.55M |
|
2349
Vipshop
VIPS
$8.97B
| $278K | ﹤0.01% |
26,377
-66,479
| -72% | -$701K |
|
2350
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $277K | ﹤0.01% |
+19,279
| New | +$277K |
|